MK2-Deficient Mice Are Bradycardic and Display Delayed Hypertrophic Remodeling in Response to a Chronic Increase in

Matthieu Ruiz1,2, Maya Khairallah3,2, Dharmendra Dingar3,2

  • 1Department of Medicine Université de Montréal Québec Canada.

Insights

Mitogen-activated protein kinase-activated protein kinase-2 (MK2) deficiency impacts heart rate regulation, mitochondrial function, and cardiac remodeling. MK2-null mice show altered autonomic control and improved response to pressure overload.

Area of Science:

  • Cardiovascular Biology
  • Molecular Cardiology
  • Mitochondrial Physiology

Background:

  • Mitogen-activated protein kinase-activated protein kinase-2 (MK2) is a key kinase downstream of p38α/β.
  • Understanding MK2's role in cardiac function is crucial for cardiovascular research.

Purpose of the Study:

  • To investigate the cardiac phenotype of mice lacking MK2.
  • To elucidate MK2's involvement in cardiac autonomic regulation, mitochondrial function, and response to stress.

Main Methods:

  • Phenotypic analysis of MK2-null (MK2-/-) and wild-type (MK2+/+) mice.
  • Assessment of cardiac function, electrophysiology, myocyte calcium handling, and mitochondrial activity.
  • Evaluation of cardiac remodeling and function under pressure overload conditions.

Main Results:

  • MK2-/- mice exhibited prolonged R-R intervals and P-R segments, indicating altered autonomic regulation.
  • Cardiac mitochondria from MK2-/- mice showed decreased calcium sensitivity of the mitochondrial permeability transition pore.
  • MK2 deficiency attenuated cardiac remodeling and systolic dysfunction during pressure overload.

Conclusions:

  • MK2 plays a significant role in the autonomic regulation of heart rate.
  • MK2 influences cardiac mitochondrial function and calcium handling.
  • MK2 is implicated in the early stages of myocardial remodeling and adaptation to pressure overload.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
220
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
147
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
148